Article Versions Notes

Fagel ND, Leuven SGJ, Kikkert WJ, de Leau MM, van Heerebeek L, Riezebos RK. The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial. Journal of Clinical Medicine. 2021; 10(16):3636. https://doi.org/10.3390/jcm10163636

Fagel, Nick D., Stefan G. J. Leuven, Wouter J. Kikkert, Michelle M. de Leau, Loek van Heerebeek, and Robert K. Riezebos. 2021. "The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial" Journal of Clinical Medicine 10, no. 16: 3636. https://doi.org/10.3390/jcm10163636

Fagel, N. D., Leuven, S. G. J., Kikkert, W. J., de Leau, M. M., van Heerebeek, L., & Riezebos, R. K. (2021). The Effect of the Timing of Invasive Management on Cardiac Function in Patients with NSTE-ACS, Insights from the OPTIMA-2 Randomized Controlled Trial. Journal of Clinical Medicine, 10(16), 3636. https://doi.org/10.3390/jcm10163636